Endothelin antagonist

Details Endothelin antagonist Endothelin antagonist

2005-10-11

2005-10-11

Russel, Jeffrey Edwin (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S331000

Reexamination Certificate

active

06953780

ABSTRACT:
The instant invention relates to some tripeptide derivatives having activity against endothelin a process for preparing them, pharmaceutical composition containing the same and their use in prevention or treatment of some diseases associated with endothelin.

REFERENCES:
patent: 5260276 (1993-11-01), Cody et al.
patent: 5691315 (1997-11-01), Ishikawa et al.
patent: 0 548 441 (1993-06-01), None
patent: 7-228594 (1995-08-01), None
Itoh et al. A Novel Endothelin ETA Receptor Antagonist, BQ-485 . . . Biochemical And Biophysical Research Communications. Sep. 15, 1993, vol. 195, No. 2, pp. 969-975.
Spellmeyer et al,Bioorganic Medicinal Chemistry Letters, 3(4):519-524 (1993).

Affiliated with

Also associated with

Rating

Endothelin antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endothelin antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin antagonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3490713